[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100619674":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":15,"centralContacts":19,"locations":28,"responsibleParty":111,"collaborators":114,"id":118,"slug":119,"hasResults":120,"nctId":121,"briefTitle":122,"officialTitle":123,"acronym":124,"eligibilityCriteria":125,"healthyVolunteers":120,"sex":126,"minAge":127,"maxAge":10,"enrollmentInfo":128,"targetDuration":131,"studyType":132,"phases":10,"briefSummary":133,"conditions":134,"keywords":136,"overallStatus":31,"whyStopped":10,"lastUpdateSubmitDate":143,"lastUpdatePostDateStruct":144,"startDateStruct":147,"completionDateStruct":149,"leadSponsor":151,"locationsCount":152},{"fullName":5,"class":6},"Inha University Hospital","OTHER",[8,12],{"label":9,"type":10,"description":11,"interventionNames":10},"High Risk Group",null,"Patients classified as having a high risk of atrial fibrillation by the SmartECG-AF AI algorithm.",{"label":13,"type":10,"description":14,"interventionNames":10},"Low to Intermediate Risk Group","Patients classified as having a low to intermediate risk of atrial fibrillation by the SmartECG-AF AI algorithm.",[16],{"name":17,"affiliation":5,"role":18},"Yong-Soo Baek, MD, PhD","PRINCIPAL_INVESTIGATOR",[20,24],{"name":17,"role":21,"phone":22,"phoneExt":10,"email":23},"CONTACT","+82-32-890-2200","existsoo@inha.ac.kr",{"name":25,"role":21,"phone":26,"phoneExt":10,"email":27},"Hyoung Seok Lee, MD","+82-32-890-3575","hyoungseok_lee@inha.ac.kr",[29,48,61,77,94],{"facility":30,"status":31,"city":32,"state":10,"zip":10,"country":33,"countryCode":10,"cosmosGeoPoint":34,"geoPoint":39,"contacts":40},"Korea University Ansan Hospital","RECRUITING","Ansan","South Korea",{"type":35,"coordinates":36},"Point",[37,38],126.52613,35.46836,{"lat":38,"lon":37},[41,45],{"name":42,"role":21,"phone":43,"phoneExt":10,"email":44},"Sangmi Oh","+82-31-412-5114","osm221001@gmail.com",{"name":46,"role":21,"phone":43,"phoneExt":10,"email":47},"Seung-yong Shin, M.D., Ph.D.","theshin04@naver.com",{"facility":5,"status":31,"city":49,"state":10,"zip":10,"country":33,"countryCode":10,"cosmosGeoPoint":50,"geoPoint":54,"contacts":55},"Incheon",{"type":35,"coordinates":51},[52,53],126.70515,37.45646,{"lat":53,"lon":52},[56,60],{"name":57,"role":21,"phone":58,"phoneExt":10,"email":59},"Hyerim Park","+82-32-890-2114","rimvely1126@naver.com",{"name":17,"role":21,"phone":22,"phoneExt":10,"email":23},{"facility":62,"status":31,"city":63,"state":10,"zip":10,"country":33,"countryCode":10,"cosmosGeoPoint":64,"geoPoint":68,"contacts":69},"Jeju National University Hospital","Jeju City",{"type":35,"coordinates":65},[66,67],126.52194,33.50972,{"lat":67,"lon":66},[70,74],{"name":71,"role":21,"phone":72,"phoneExt":10,"email":73},"Jin-hee Kim","+82-64-717-6000","wpwndurh77@naver.com",{"name":75,"role":21,"phone":72,"phoneExt":10,"email":76},"Ki Yung Boo, MD, PhD","pidori@hanmail.net",{"facility":78,"status":31,"city":79,"state":10,"zip":10,"country":33,"countryCode":10,"cosmosGeoPoint":80,"geoPoint":84,"contacts":85},"Korea University Guro Hospital","Seoul",{"type":35,"coordinates":81},[82,83],126.9784,37.566,{"lat":83,"lon":82},[86,90],{"name":87,"role":21,"phone":88,"phoneExt":10,"email":89},"Yoonhee Choi","+82-2--2626-2336","grkmcgrca009@kumc.or.kr",{"name":91,"role":21,"phone":92,"phoneExt":10,"email":93},"Dae-in Lee, MD, PhD","+82-2-2626-1114","acttopia@gmail.com",{"facility":95,"status":31,"city":96,"state":10,"zip":10,"country":33,"countryCode":10,"cosmosGeoPoint":97,"geoPoint":101,"contacts":102},"Ajou University Hospital","Suwon",{"type":35,"coordinates":98},[99,100],127.00889,37.29111,{"lat":100,"lon":99},[103,107],{"name":104,"role":21,"phone":105,"phoneExt":10,"email":106},"Jihee Kang","+82-31-219-4329","haagendasss@gmail.com",{"name":108,"role":21,"phone":109,"phoneExt":10,"email":110},"Kwang-No Lee, MD, PhD","+82-31-219-7830","knlee81@ajou.ac.kr",{"type":18,"investigatorFullName":112,"investigatorTitle":113,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"Yong-Soo Baek","Professor",[115],{"name":116,"class":117},"DeepCardio Co., Ltd.","UNKNOWN","100619674","ai-based-prediction-of-atrial-fibrillation-in-esus-patients-with-icm-100619674",false,"NCT07347691","AI-Based Prediction of Atrial Fibrillation in ESUS Patients With ICM","Predicting Atrial Fibrillation in Patients With Post-implantable Cardiac Monitor Implementation : A Prospective, Long-term Follow-up Study Using Comprehensive AI ECG Analysis : Multicenter Prospective Study","SMART-ESUS","Inclusion Criteria:\n\n* Patients aged 30 years or older.\n* Patients diagnosed with Embolic Stroke of Undetermined Source (ESUS) who have undergone or are scheduled for Implantable Cardiac Monitor (ICM) implantation.\n* Patients who have undergone at least one 12-lead ECG examination within 2 weeks before or after the date of ICM implantation.\n* Patients maintaining Sinus Rhythm on ECG at the time of enrollment.\n* Patients who have voluntarily signed the informed consent form.\n\nExclusion Criteria:\n\n* Patients diagnosed with Atrial Fibrillation (AF) at least once prior to the date of enrollment.\n* Patients whose ICM battery status is at Elective Replacement Interval (ERI), making recording impossible.\n* Patients whose ECGs cannot be analyzed by the AI algorithm (SmartECG-AF) due to severe artifacts or noise, or are incompatible with digital analysis.","ALL","30 Years",{"count":129,"type":130},92,"ESTIMATED","12 Months","OBSERVATIONAL","This study investigates patients with Embolic Stroke of Undetermined Source (ESUS) who have received an Implantable Cardiac Monitor (ICM). The main purpose is to evaluate the predictive value of an Artificial Intelligence ECG analysis tool, named SmartECG-AF.\n\nParticipants will be classified into two groups based on the AI analysis: a \"High Risk\" group and a \"Low to Intermediate Risk\" (control) group. The study aims to compare the incidence rate of atrial fibrillation (AF) events over time between these two groups. Additionally, the study will analyze the relationship between the AI-predicted risk levels and the occurrence of major cardiovascular events during the follow-up period.",[135],"Embolic Stroke of Undetermined Source",[137,138,139,140,141,142],"Implantable Cardiac Monitor","Artificial Intelligence","Deep Learning","Electrocardiography","Risk Prediction","Cryptogenic Stroke","2026-01-09",{"date":145,"type":146},"2026-01-16","ACTUAL",{"date":148,"type":146},"2025-11-19",{"date":150,"type":130},"2028-05",{"name":5,"class":6},5]